Bristol-Myers Squibb: Swords, Ireland
INDEX
|
CONTACT US
Argentina
Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Greece
Hungary
India
Ireland
Italy
Japan
Korea
Mexico
The Netherlands
New Zealand
Norway
Poland
Portugal
Russia
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
United States
BMS.com-US
Our Company
Our Mission & Commitment
Key Facts
Leadership
Our Operations
Governance
Compliance & Ethics
History
Diversity & Inclusion
Achievements
Business Information
|
R&D
In the Pipeline
Investigational Compound News
Therapeutic Areas of Focus
R&D Organization
Major R&D Facilities
Clinical Trials
Investigator- Sponsored Research
|
Products
Help Paying For Your Medicine
Counterfeit Drugs
Medical Information Inquiries
|
News
Press Releases
Publications
Media Library
Key Facts
Leadership
Financial Reporting
Features
Achievements
Media Contacts
Subscribe to e-mail alerts
|
Investors
Key Facts
Stock Information
SEC Filings
Financial Reporting
Events & Presentations
Shareholder Services
Investor Contacts
|
Partnering
Why Partner With Us?
Areas of Interest
Our Process
Our Partners
Partnering News
Partnering Contact
|
Responsibility
Bristol-Myers Squibb Foundation
Sustainability
Help Paying For Your Medicine
Building Our Communities
Grants & Giving
Position on Key Issues
Transparency
Clinical Trials
Combating Counterfeit Drugs
Disaster Relief & Product Donations
Achievements
Access to Medicines
|
Careers
Job Opportunities
Our Culture
Diversity & Inclusion
Developing Our People
Military Veterans Resources
University Recruitment
Achievements
Benefits
Apply Now
Sustainability
Responsibility Message from CEO
About this GRI Report
Executive Summary
Sustainability Issues
Sustainability Goals and Key Indicators
Worldwide Facilities
Alphabetical
Region
Asia
Europe
Braine-L´Alleud
Moreton, UK
Agen, France
Fontenay, France
Rueil-Malmaison
Cruiserath, Ireland
Swords, Ireland
Anagni, Italy
North America
Latin America
Stakeholder Engagement
Governance and Management
Economic Responsibility
Social Progress
Environmental Performance
Go Green
Subject Index
Downloads
BMS.com Home
»
Sustainability
»
Worldwide Facilities
»
Europe
»
Swords, Ireland
Swords, Ireland
Facts and Figures
Situated on 17 acres in Swords.
The facility manufactures active pharmaceutical ingredients for a range of products including cardiovascular, antiviral and cancer drugs.
Community and Social Progress
Swords Laboratories operates a safety management system that strives to continuously improve how safety issues are addressed onsite.
The site has been the recipient of a safety award from the National Irish Safety Organisation every year since 2005.
Environmental Performance
Swords Laboratories is licensed by the Environmental Protection Agency, which requires the facility to have in place an environmental management system. The Integrated Pollution Prevention & Control licence also sets strict emission limits, which are verified by the EPA. The agency takes samples and also performs unannounced audits of the facility at least twice a year.
Examples include the following achievements of the site’s energy focused team in 2007:
A 29 percent reduction in natural gas usage by installing a smaller combustor unit in the site's air emissions abatement unit and by reducing the number of air changes in some parts of the site, thereby reducing steam demand.
An 11 percent reduction in electricity usage by optimizing the set-points of a number of chiller units.
A 37 percent reduction on the amount of energy required to produce liquid nitrogen onsite.
Swords Laboratories has adopted the river otter as its endangered species and works with the Irish Wildlife Trust to educate local school children and raise awareness through an annual clean-up of the local river ward, which runs alongside the site. In 2008 a new project was undertaken with a local school to rear salmon fry in their classroom and then release the fry into the river ward.
Energy
Preservation of our natural resources is one of Bristol-Myers Squibb’s key commitments. Both our Swords and Cruiserath facilities are operating to the new European Energy Management standard EN 16001, which entails a systematic approach to sustainable energy efficiency.
The sites are committed to energy and carbon emissions reduction. Each site has a dedicated energy team lead by a full time energy manager. The reduction of energy is a core objective for both sites and receives the full support of senior management on each site.
This structured approach to energy efficiency has resulted in significant energy reductions. The Cruiserath facility has reduced its energy consumption by over 20% since 2005 with 16% of this reduction coming in the period 2008 – 2009 while manufacturing output increased by over 40%. The Swords Site reduced energy usage over the period 2005 -2009 by 14%.
Over the last 4 years, BMS Irelands Carbon footprint has been reduced by over 8,600 tonnes and we continue to pursue innovative ways to further reduce our energy use.
Facility Contact Information
+353-1813-9000
You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.